Inventor · disambiguated record
John Francis Lyons
Also filed as: LYONS JOHN · LYONS JOHN B · LYONS JOHN F · LYONS JOHN FRANCIS
14 granted patents·23 pending applications·393 citations·filing 1998–2018
93Inventor score
Files withASTEX THERAPEUTICS LTD10LYONS JOHN4GALLAGHER NEIL JAMES3WOOD JILL E3CURRY JAYNE ELIZABETH2
Top patents by PatentIndex Score
37 records- 0196US6998391B2Method for treating diseases associated with abnormal kinase activitySUPERGEN INC·Filed 2002·Granted Feb 14, 2006·115 cites·20 claims
- 0296US6187799B1Inhibition of raf kinase activity using aryl ureasONYX PHARMACEUTICALS·Filed 1998·Granted Feb 13, 2001·118 cites·18 claims
- 0394US8399442B2Pharmaceutical compoundsBERDINI VALERIO·Filed 2006·Granted Mar 19, 2013·62 cites·26 claims
- 0493US8277807B2Pharmaceutical combinationsGALLAGHER NEIL JAMES·Filed 2007·Granted Oct 2, 2012·39 cites·20 claims
- 0588US7307071B2RAF-MEK-ERK pathway inhibitors to treat cancerONYX PHARMA INC·Filed 2002·Granted Dec 11, 2007·31 cites·8 claims
- 0686US8435970B2Pharmaceutical combinations of 1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-ureaCURRY JAYNE ELIZABETH·Filed 2007·Granted May 7, 2013·8 cites·24 claims
- 0784US11236047B2Combination of isoindolinone derivatives with SGI-110ASTEX THERAPEUTICS LTD·Filed 2018·Granted Feb 1, 2022·2 cites·21 claims
- 0876US8541461B2Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulatorsTHOMPSON NEIL THOMAS·Filed 2006·Granted Sep 24, 2013·2 cites·26 claims
- 0975US9428439B2Hydrobenzamide derivatives as inhibitors of Hsp90ASTEX THERAPEUTICS LTD·Filed 2014·Granted Aug 30, 2016·2 cites·11 claims
- 1075US8916552B2Pharmaceutical combinationsGALLAGHER NEIL JAMES·Filed 2007·Granted Dec 23, 2014·3 cites·4 claims
- 1173US8779132B2Pharmaceutical compoundsCONGREVE MILES STUART·Filed 2007·Granted Jul 15, 2014·3 cites·8 claims
- 1273US8404718B2Combinations of pyrazole kinase inhibitorsCURRY JAYNE ELIZABETH·Filed 2010·Granted Mar 26, 2013·5 cites·22 claims
- 1372US8883790B2Pharmaceutical combinationsGALLAGHER NEIL JAMES·Filed 2007·Granted Nov 11, 2014·2 cites·8 claims
- 1467US2010063088A1Raf Kinase InhibitorsWOOD JILL E·Filed 2009·Application pending·0 cites
- 1563US6977247B2Sequential therapy comprising a 20(S)-camptothecin and a pyrimidine base analogSUPERGEN INC·Filed 2002·Granted Dec 20, 2005·1 cites·10 claims
- 1662US2005209186A1Method for treating chronic myelogenous leukemiaLYONS JOHN·Filed 2004·Application pending·0 cites
- 1760US2012178780A1Raf kinase inhibitorsWOOD JILL E·Filed 2012·Application pending·0 cites
- 1859US2005256174A1Raf kinase inhibitorsWOOD JILL E·Filed 2005·Application pending·0 cites
- 1959US2005037992A1Composition and method for treating neurological disordersFiled 2004·Application pending·0 cites
- 2055US2009091079A1Three-dimensional logic puzzleLYONS JR JOHN F·Filed 2007·Application pending·0 cites
- 2155US2009096160A1Logic puzzleLYONS JR JOHN F·Filed 2007·Application pending·0 cites
- 2253US2003147813A1Method for treating chronic myelogenous leukemiaFiled 2002·Application pending·0 cites
- 2353US2010021420A1Combinations of pyrazole derivatives for the inhibition of cdks and gsk'sASTEX THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 2452US2007254835A1Composition and method for treating neurological disordersLYONS JOHN·Filed 2007·Application pending·0 cites
- 2551US2006052334A1Sequential therapy comprising a 20(S)-camptothecian and a pyrimidine base analogRUBINFELD JOSEPH·Filed 2005·Application pending·0 cites
- 2650US2006140947A1Method for treating diseases associated with abnormal kinase activityLYONS JOHN·Filed 2005·Application pending·0 cites
- 2750US2009082370A1Pharmaceutical Combinations of PK Inhibitors and Other Active AgentsTHOMPSON NEIL THOMAS·Filed 2007·Application pending·0 cites
- 2850US2007117776A1Low Dose Therapy Of DNA Methylation InhibitorsLYONS JOHN·Filed 2006·Application pending·0 cites
- 2948US2009036435A1Pharmaceutical CompoundsASTEX THERAPEUTICS LTD·Filed 2006·Application pending·0 cites
- 3047US2001006975A1Raf kinase inhibitorsBAYER CORP AND ONYX PHARMACEUT·Filed 2001·Application pending·0 cites
- 3145US2011159111A1Pharmaceutical combinationsASTEX THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 3244US2004005944A1String package for a game racquet and method of stringing a racquetWILSON SPORTING GOODS INC·Filed 2002·Application pending·0 cites
- 3344US2009318430A1Medical use of cyclin dependent kinases inhibitorsASTEX THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 3442US2009263398A1Pharmaceutical combinationsASTEX THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 3541US2007208015A15-Morpholinylmethylthiophenyl Pharmaceutical Compounds As P38 MAP Kinase ModulatorsASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
- 3638US2008161355A1Combinations of Pyrazole Kinase Inhibitors and Further Antitumor AgentsASTEX THERAPEUTICS LTD·Filed 2006·Application pending·0 cites
- 3738US2008161251A1Pharmaceutical CompoundsASTEX THERAPEUTICS LTD·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Francis Lyons files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →